LYSOPHOSPHATIDYLCHOLINE - A CHEMOTACTIC FACTOR FOR HUMAN-MONOCYTES AND ITS POTENTIAL ROLE IN ATHEROGENESIS
LYSOPHOSPHATIDYLCHOLINE - A CHEMOTACTIC FACTOR FOR HUMAN-MONOCYTES AND ITS POTENTIAL ROLE IN ATHEROGENESIS
复制标题
DOI:
10.1073/pnas.85.8.2805
复制
发表时间:
1988-04-01
影响因子:
11.1
通讯作者:
STEINBERG, D
中科院分区:
文献类型:
--
作者:
QUINN, MT;PARTHASARATHY, S;STEINBERG, D
Native low density lipoprotein (LDL) does not affect monocyte/macrophage motility. On the other hand, oxidatively modified LDL inhibits the motility of resident peritoneal macrophages yet acts as a chemotactic factor for circulating human monocytes. We now show that lysophosphatidylcholine (lyso-PtdCho), which is generated by a phospholipase A2 activity during LDL oxidation, is a potent chemotactic factor for monocytes. It is not chemotactic for neutrophils or for resident macrophages. Platelet-activating factor, after treatment with phospholipase A2, becomes chemotactic for monocytes, whereas the intact factor is not. Synthetic 1-palmitoyl-lyso-PtdCho showed chemotactic activity comparable to that of the lyso-PtdCho fraction derived from oxidized LDL. The results suggest that lyso-PtdCho in oxidized LDL may favor recruitment of monocytes into the arterial wall during the early stages of atherogenesis. Generation of lyso-PtdCho, either from LDL itself or from membrane phospholipids of damaged cells, could play a more general role in inflammatory pocesses throughout the body.